MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase 1 study of Subcutaneous BRIUMVI ...
Natco Pharma and Lupin gained FDA approval for bioequivalent generic eribulin mesylate injection, potentially reducing ...
Final Bria-IMT™ Phase 2 data show 55% >1 year and 27% >2-year survival in heavily pre-treated metastatic breast cancer (MBC) ...
Abstract: The necessity of lowering emissions in the transportation sector is driving growing interest in fuel cell electric vehicles (FCEVs). Nonetheless, these vehicles still face several challenges ...
Abstract: Phase unwrapping is a critical step in fringe projection profilometry (FPP), yet achieving a balance between robustness and efficiency remains challenging. In this paper, we propose a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results